In addition, people with active malaria presented higher antibody levels against these transferrin peptides, and the absence of significant differences in IgG levels against the transferrin peptides among the samples originating from uninfected individuals who never had malaria or had malaria in the past (before the study sampling) strengthens that hypothesis. This evidence concerns the gene TF and malaria.